معرفی
Hasan SALKIN serves as an Associate Professor at Istanbul Beykent University's Faculty of Medicine, Department of Basic Medical Sciences. Previously, he was a Doctor Lecturer (2021-2024) and Lecturer (2016-2021) at Beykent University's Vocational School, Medical Services and Techniques Department. His academic career demonstrates steady progression within the same institution, indicating strong institutional commitment and recognition of his expertise in medical sciences.
His educational background includes:
- Doctorate (2016-2020) from Erciyes University, Institute of Health Sciences, with thesis on "Investigation of CD44 inhibitory and tumor suppressor effects of conditioned medium obtained from human adipose-derived mesenchymal stem cells treated with TGF-B1 gene therapy on breast cancer cells: In vitro study"
- Degree (2011-2015) from Erciyes University, Institute of Health Sciences, with thesis on "Effects of TGF-β1 transfected pulpal stem cells and PRP application on chondrogenic differentiation"
- Licence (2007-2011) from Republic University, Faculty of Science
Dr. SALKIN's research primarily focuses on stem cell biology, particularly dental pulp-derived mesenchymal stem cells and their therapeutic applications. His work extensively investigates TGF-β1 signaling pathways, chondrogenic differentiation, and the effects of various compounds (including ibuprofen and thymoquinone) on stem cell behavior. His research spans regenerative medicine applications for cartilage repair, osteoarthritis treatment, and cancer therapy, demonstrating a translational approach from bench to bedside. The consistent theme across his publications is understanding how stem cell secretomes and genetic modifications can be harnessed for tissue regeneration and disease treatment.
Analysis of his publication trends reveals a clear evolution from basic stem cell characterization toward increasingly sophisticated therapeutic applications. Early work focused on fundamental mechanisms of stem cell differentiation, while recent publications explore exosome-based therapies, cancer applications, and neurological receptor interactions. His research bridges multiple disciplines including dentistry, orthopedics, oncology, and neuroscience, demonstrating interdisciplinary thinking. The consistent use of dental pulp as a stem cell source throughout his career highlights his specialized expertise in this accessible and promising stem cell niche.
Dr. SALKIN has supervised at least two theses: "Evaluation of the effects of mesenchymal stromal cell conditioned medium on chondrocytes" (2023) by THE DEVIL IS NOT AFRAID and "Investigation of the effect of short-term minocycline application on acclimatization to hypoxia of different severities in the spinal cord (C3-C5) region" (2021) by KAĞAN KILIÇÇALAN. His international research exposure includes participation in the LLP/ERASMUS INTENSIVE PROGRAM "STEM CELL APPLICATIONS: FROM BENCH SIDE TO BED SIDE" at Szechenyi Istvan University in 2014, indicating engagement with the broader European research community.
